EUCTR2013-000456-17-NL进行中（未招募）1 期
Plaque at risk (ParisK): Molecular imaging of plaque vulnerability using 18F-choline PET-CT and MRI in carotid artery atherosclerosis patients - ParisK
niversity Hospital Maastricht0 个研究点目标入组 25 人开始时间: 2013年8月12日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Patients with symptomatic carotid artery stenosis, who are scheduled for carotid endarterectomy or conservative treatment.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 25
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 25
排除标准
- •-Severe comorbidity, dementia, pregnancy, breast feeding;
- •-Serious neurological deficits (hemiparalysis, complete aphasia).
- •-Severe heart failure and severe pulmonary dysfunction dependent on oxygen supply;
- •-Patients with contra-indications for MRI
研究者
相似试验
招募中
3 期
Plaque at risk (ParisK): Molecular imaging of plaque vulnerability using 18F-choline PET-MRI in patients with carotid artery atherosclerosisatherosclerotic plaquecalcification in the vessel wall10003216arteriosclerosisNL-OMON47871Medisch Universitair Ziekenhuis Maastricht25
已完成
不适用
Molecular imaging of coronary plaque vulnerability using 18F-fluorocholine PET-MRI in patients with coronary artery diseasearteriosclerosisNL-OMON47096Medisch Universitair Ziekenhuis Maastricht35
撤回
不适用
sing Molecular Plaque Imaging to Ascertain Cardiovascular Risk in Patients with Sleep ApnoeaAtherosclerotic Cardiovascular DiseaseSleep ApnoeaCardiovascular - Coronary heart diseaseRespiratory - Sleep apnoeaACTRN12618001327279South Australian Health and Medical Research Institute (SAHMRI)50
招募中
不适用
Brain imaging of dementiaPatients with dementia and healthy subjects of the same age group who meet all the criteria.JPRN-UMIN000046094niversity of Fukui150
已完成
不适用
Investigation of plaque vulnerability: Identification of atherosclerotic plaque angiogenesis using Bevacizumab-800CW and optoacoustic imaging: a single center proof of concept study (CAROTID-OPTOLIGHT)NL-OMON45786niversitair Medisch Centrum Groningen15